Post-Meal Exercise may Attenuate the Glycemic Response to a Carbohydrate Load: Important Implications for Adults who are Obese, with Pre-Diabetes or Diabetes, and/or At-Risk for Dementia
DOI:
https://doi.org/10.17140/OROJ-2-113Keywords:
Diabetes; Dementia; Elevated blood glucose; Insulin resistance; Obesity; Postmeal exercise; Prevention.Abstract
Obese individuals are at risk for insulin resistance and type 2 diabetes. Both obesity
and diabetes are known risk factors for dementia, already a recognized global public health
issue. Up to one-third of Alzheimer-type dementia may be attributed to potentially-modifiable
risk factors such as the prevention of obesity and diabetes; physical exercise, particularly postmeal exercise, can play an important role in such prevention. This paper reviews research on
the link between obesity and insulin resistance related to the conditions of pre-diabetes and
diabetes, the consequences of elevated blood glucose (hyperglycemia) that result from a carbohydrate-rich diet and insulin resistance, the potential short and long term health consequences
of elevated blood glucose, and the promising effects of post-meal exercise to stabilize blood
glucose levels after consuming a carbohydrate load. Mitigating elevated blood glucose after
consumption of snacks and meals in obese adults who are at-risk for, or who have diabetes,
could improve glycemic control, decrease the need for medication (or decrease the dosages
needed), delay the onset of long term complications of the diabetes, and decrease dementia risk.
Further, facilitating stable levels of blood glucose in adults diagnosed with dementia through
regular post-meal light exercise may positively affect mood and behavior, important aspects
of dementia management, as well as physical health. If post-meal exercise does prove to effectively blunt the blood glucose spike after a meal, it could be a low-cost convenient method
to prevent the damaging consequences of elevated blood glucose.
References
Lunnon K, Mill J, Smith RG, et al. Blood methylomic signa-tures of presymptomatic dementia in elderly subjects with type 2 diabetes mellitus. Neurobiol Aging. 2015. doi: 10.1016/j.neu-robiolaging.2014.12.023
Cheng PY, Sy HN, Wu SL, Wang WF, Chen YY. Newly diag-nosed type 2 diabetes and risk of dementia: a population-based 7-year follow-up study in Taiwan. J Diabetes Complicat. 2012; 26: 382-387. doi: 10.1016/j.jdiacomp.2012.06.003
Lu ZK, Li M, Yuan J, Wu J. The role of cerebrovascular dis-ease and the association between diabetes mellitus and dementia among aged medicare beneficiaries. Int J Geriatr Psych. 2015. doi: 10.1002/gps.4293
Li X, Song D, Leng SX. Link between type 2 diabetes and Al-zheimer’s disease: from epidemiology to mechanism and treat-ment. Clin Interv Aging. 2015; 10: 549-560. doi: 10.2147/CIA. S74042
Nepal B, Brown L, Anstey K. Rising midlife obesity will worsen future prevalence of dementia. PLOS One. 2014; 9(9): e99305. doi: 10.1371/journal.pone.0099305
Albanese E, Davis B, Jonsson PV, et al. Overweight and obe-sity in midlife and brain structure and dementia 26 years later: The AGES-Reykjavik study. Am J Epidermiol. 2015; 181(9): 672-679. doi: 10.1093/aje/kwu331
World Health Organization. Dementia: A public health prior-ity. Geneva, Switzerland: World Health Organization. 2012.
American Diabetes Association. Statistics about diabetes. Available at: http://www.diabetes.org/diabetes-basics/statistics/. 2015; Accessed July 24, 2015.
Hribal ML, Oriente F, Accili D. Mouse models of insulin re-sistance. Am J Physiol Endocrinol Metab. 2002. doi: 10.1152/ ajpendo.00561.2001
Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev. 1995; 75: 473-486.
Saltiel AR, Kahn CR. Insulin signaling and the regulation of glucose and lipid metabolism. Nature. 2001; 414: 799-806.
American Diabetes Association. Complications. Available at: http://www.diabetes.org/living-with-diabetes/complications/ 2015; Accessed July 24, 2015.
Qatanani M, Lazar MA. Mechanisms of obesity-associated insulin resistance: many more choices on the menu. Gene Dev. 2007; 21: 1443-1455.
Rajala MW, Obici S, Scherer PE, Rossetti L. Adipose-de-rived resistin and gut-derived resistin-like molecules selectively impair insulin action on glucose production. J Clin Invest. 2003; 111: 225-230.
Yang Q, Graham TE, Mody N, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature. 2005; 436: 356-362. doi: 10.1038/nature03711
Kiliaan AJ, Arnoldussen IAC, Gustafson DR. Review: adi-pokines: a link between obesity and dementia? Lancet Neurol. 2014; 13(9): 913-923. doi: 10.1016/S1474-4422(14)70085-7
Iadecola C. The pathophysiology of vascular dementia. Neu-ron. 2013; 80: 844-866.
Rask E, Olsson T, Soderberg S, et al. Tissue-specific dys-regulation of cortisol metabolism in human obesity. J Clin En-docrinol Metab. 2001; 86: 1418-1421.
Popp J, Wolfsgruber S, Heuser I, et al. Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer’s type. Neurobiol Aging. 2015; 36: 601-607. doi: 10.1016/j.neurobiolaging.2014.10.03
Rasouli N, Kern PA. Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab. 2008; 93(11 Suppl 1): S64-S73. doi: 10.1210/jc.2008-1613
Cao H. Adipocytokines in obesity and metabolic disease. J Endocrinol. 2014; 220(2): T47-T59. doi: 10.1530/JOE-13-0339
Dandona P, Aljada A, Bandyopadhyay A. Inflammation: The link between insulin resistance, obesity and diabetes. Trends Im-munol. 2004; 25: 4-7. doi: 10.1016/j.it.2003.10.013
Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006; 116: 1793-1801. doi: 10.1172/ JCI29069
Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the developmentof obesity-related insulin resistance. J Clin Invest. 2003; 112:1821-1830.
O’Keefe JH, Gheewala NM, O’Keefe JO. Dietary strategies for improving post-prandial glucose, lipids, inflammation, and cardiovascular health. J Am Coll Cardiol. 2008; 51(3): 249-255. doi: 10.1016/j.jacc.2007.10.016
Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante Jr AW. Obesity is associated with macrophage ac-cumulation in adipose tissue. J Clin Invest. 2003; 112: 1796- 1808.
Weisberg SP, Hunter D, Huber R, et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest. 2006; 116: 115-124. doi: 10.1172/JCI24335
Kanda H, Tateya S, Tamori Y, et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest. 2006; 116: 1494- 1505.
Simpson KA,Martin NM, Bloom SR. Hypothalamic regula-tion of appetite. Expert Rev Endocrinol Metab. 2008; 3(5): 577- 592.
Pocai A, Obici S, Schwartz GJ, Rossetti L. A brain-liver cir-cuit regulates glucose homeostasis. Cell Metab. 2005; 1: 53-61. doi: 10.1016/j.cmet.2004.11.001
Okamoto H, Nakae J, Kitamura T, Park BC, Dragatsis I, Ac-cili D. Transgenic rescue of insulin receptor deficient mice. J Clin Invest. 2004; 114: 214-223. doi: 10.1172/JCI200421645
Pocai A, Morgan K, Buettner C, Gutierrez-Juarez R, Obici S, Rossetti L. Central leptin acutely reverses diet-induced hepatic insulin resistance. Diabetes. 2005; 54: 3182-3189. doi: 10.2337/ diabetes.54.11.3182
Obici S, Zhang BB, Karkanias G, Rossetti L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med. 2002; 8: 1376-1382. doi: 10.1038/nm1202-798
Yan SF, D’Agati V, Schmidt AM, Ramasamy R. Receptor for Advanced Glycation Endproducts (RAGE): a formidable force in the pathogenesis of the cardiovascular complications of dia-betes & aging. Curr Molecular Med. 2007; 7(8): 699-710. doi: 10.2174/156652407783220732
Simm A, Wagner J, Gursinsky T, et al. Advanced glycation endproducts: a biomarker for age as an outcome predictor af-ter cardiac surgery? Exp Gerontol. 2007; 42(7): 668-675. doi: 10.1016/j.exger.2007.03.006
Zimmerman GA, Meistrell M 3rd, Bloom O, et al. Neurotox-icity of advanced glycation endproducts during focal stroke and neuroprotective effects of aminoguanidine. Proc Natl Acad Sci USA. 1995; 92(9): 3744-3748.
Srikanth V, Maczurek A, Phan T, et al. Advanced glycation endproducts and their receptor RAGE in Alzheimer’s disease. Neurobiol Aging. 2011; 32(6): 763-767. doi: 10.1016/j.neuro-biolaging.2009.04.016
Goldin A, Beckman JA, Schmidt AM, Creager MA. Ad-vanced glycation end products: sparking the development of di-abetic vascular injury. Circulation. 2006; 114(6): 597-605. doi: 10.1161/CIRCULATIONAHA.106.621854
Peppa M, Uribarri J, Vlassara H. Glucose, advanced glyca-tion end products, and diabetes complication: what is new and what works. Clin Diabetes. 2004; 21(4): 186-187. doi: 10.2337/ diaclin.21.4.186
Misciagna G, DeMichele G, Cisternino A, Guerra V, Logoscino G, Freudenheim JL. Dietary carbohydrates and gly-cated proteins in the blood in non-diabetic subjects. J Am Coll Nutr. 2005; 24(1): 22-29.
Giugliano D, Ceriello A, Esposito K. The effects of diet on inflammation: emphasis on the metabolic syndrome. J Am Coll Cardiol. 2006; 48(4): 677-685. doi: 10.1016/j.jacc.2006.03.052
Esposito K, Nappo F, Marfella R, et al. Inflammatory cyto-kine concentrations are acutely increased by hyperglycemia in humans: Role of oxidative stress. Circulation. 2002; 106(16): 2067-2072. doi: 10.1161/01.CIR.0000034509.14906.AE
Buyken AE, Goletzke J, Joslowski G, et al. Association be-tween carbohydrate quality and inflammatory markers: system-atic review of observational and interventional studies. Am J Clin Nutr. 2014; 99(4): 813-833. doi: 10.3945/ajcn.113.074252
Lowe GD. Circulating inflammatory markers and risks of car-diovascular and non-cardiovascular disease. J Thromb Haemost. 2005; 3(8): 1618-1627. doi: 10.1111/j.1538-7836.2005.01416.x
Seaman DR. The diet-induced proinflammatory state: a cause of chronic pain and other degenerative diseases? J Ma-nipulative Physiol Ther. 2002; 25(3): 168-179.
Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care. 2004; 27: 813-823. doi: 10.2337/diacare.27.3.813
Rakoff-Nahoum S. Why cancer and inflammation? Yale J Biol Med. 2006; 79: 123-130.
Dunford M, Doyle J. Nutrition for Sport and Exercise. 2nd ed. Wadsworth, Belmont, CA. 2008; 115-116.
Standards of Medical Care in Diabetes-2012. Diabetes Care. 2012; 35(Suppl 1): S11-S63. doi: 10.2337/dc12-s011
Borghouts LB, Keizer HA. Exercise and insulin sensitivity: a review. Int J Sports Med. 2000; 21(1): 1-12. doi: 10.1055/s-2000-8847
Peyrot M, Rubin RR, Lauritzen T, Snoek FJ, Matthews DR, Skovlund SE. Psychosocial problems and barriers to improved diabetes management: results of the Cross-National Diabetes At-titudes, Wishes and Needs (DAWN) Study. Diabet Med. 2005; 22: 1379-1385. doi: 10.1111/j.1464-5491.2005.01644.x
Heiss CJ, Levigne J, Sutton, W, Tollefson T. Postpran-dial light exercise attenuates the glycemic effect of a candy bar. Top Clin Nutr. 2014; 29(2): 132-138. doi: 10.1097/01. TIN.0000445897.59899.48
Høstmark AT, Ekeland GS, Beckstrøm AC, Meen HD. Postprandial light physical activity blunts the blood glucose increase. Prev Med. 2006; 42(5): 369-371. doi: 10.1016/j. ypmed.2005.10.001
Nygaard H, Tomten S, Høstmark AT. Slow post meal walk-ing reduces postprandial glycemia in middle-aged women. Appl Physiol Nutri Metab. 2009; 34: 1087-1092. doi: 10.1139/H09-
Manohar C, Levine JA, Nancy DK, et al. The effect of walk-ing on postprandial glycemic excursion in patients with type 1 diabetes and healthy people. Diabetes Care. 2012; 35: 2493- 2499. doi: 10.2337/dc11-2381
DiPietro L, Bribok A, Stevens MS, Hamm LF, Rimpler W. Three 15-min bouts of moderate postmeal walking significantly improves 24-h glycemic control in older people at risk for im-paired glucose tolerance. Diabetes Care. 2013; 36: 3262-3268. doi: 10.2337/dc13-0084
Colberg SR, Zarrabi L, Bennington L, et al. Postprandial walking is better for lowering the glycemic effect of dinner than predinner exercise in type 2 diabetic individuals. J Am Med Dir Assoc. 2009; 10(6): 394-397. doi: 10.1016/j.jamda.2009.03.015
Gaudet-Savard T, Ferland A, Broderick TL, et al. Safety and magnitude of changes in blood glucose levels following exercise performed in the fasted and the postprandial state in men with type 2 diabetes. EurJ Cardiovasc Prev Rehabil. 2007; 14(6): 831-836. doi: 10.1097/HJR.0b013e3282efaf38
Szewieczek J, Dulawa J, Strzałkowska D, Hornik B, Kawecki G. Impact of the short-term, intense exercise on postprandial glycemia in type 2 diabetic patients treated with gliclazide. J Diabetes Complicat. 2007; 21(2): 101-107. doi: 10.1016/j.jdia-comp.2006.05.006
Avena NM, Rada P, Hoebel BG. Evidence for sugar addic-tion: behavioral and neurochemical effects of intermittent, ex-cessive sugar intake. Neurosci Biobehav Rev. 2008; 32(1): 20- 39. doi: 10.1016/j.neubiorev.2007.04.019
Haynes RB, Taylor DW, Sackett DL. Compliance in health care. Baltimore, MD, USA: Johns Hopkins University Press; 1979.
Tan SL, Juliana S, Sakinah H. Dietary compliance and its association with glycemic control among poorly controlled type 2 diabetics. Malays J Nutr. 2011; 17(3): 287-299.
Vijan S, Stuart NS, Fitzgerald JT, et al. Barriers to follow-ing dietary recommendations in Type 2 diabetes. Diabetic Med. 2005; 22: 32-38. doi: 10.1111/j.1464-5491.2004.01342.x
Hsu TM, Kanoski SE. Blood-brain barrier disruption: mech-anistic links between Western Diet consumption and demen-tia. Front Aging Neuroscience. 2014; 6(88): 1-6. doi: 10.3389/ fnagi.2014.00088
American Diabetes Association. Postprandial blood glu-cose. Diabetes Care. 2001; 24(4): 775-778. doi: 10.2337/dia-care.24.4.775
Barclay AW, Brand-Miller JC, Wolever TMS. Glycemic index, glycemic load, and glycemic response are not the same. Diabetes Care. 2005; 28(7): 1839-1840. doi: 10.2337/dia-care.28.7.1839
Pereira MA, Swain J, Goldfine AB, Rifai N, Ludwig DS. Ef-fects of a low-glycemic load diet on resting energy expenditure and heart disease risk factors during weight loss. JAMA. 2004; 292(20): 2482-2490. doi: 10.1001/jama.292.20.2482
Polonsky KS, Given BD, Van CE. Twenty-four hour pro-files and pulsatile patterns of insulin secretion in normal and obese subjects. J Clin Invest. 1988; 81: 442-448. doi: 10.1172/ JCI113339
Mazze RS, Strock E, Wesley D, et al. Characterizing glu-cose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis. Diabetes Technol Ther. 2008; 10: 149-159. doi: 10.1089/dia.2007.0293
International Diabetes Federation. About diabetes: Compli-cations. Available at: http://www.idf.org/complications-diabetes 2014; Accessed 2015.
American Diabetes Association. Standards of medical care in diabetes-2014. Diabetes Care. 2014; 37: S14-S80. doi: 10.2337/ dc14-S014
Wroolie TE, Kenna HA, Singh MK, Rasgon NL. Associa-tion between insulin resistance and cognition in patients with depressive disorders: Exploratory analyses into age-specific effects. J Psychiatr Res. 2015; 60: 65-72. doi: 10.1016/j.jpsy-chires.2014.10.001
Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C. Po-tential for primary prevention of Alzheimer’s disease: an analy-sis of population-based data. Lancet Neurol. 2014; 13(8): 788- 794. doi: 10.1016/S1474-4422(14)70136-X
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Obesity Research (OR) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
